Anti-TNF agents linked to shingles risk with rheumatoid arthritis

01/10/2013 | MedPage Today (free registration)

Rheumatoid arthritis patients who took anti-tumor necrosis factor drugs such as etanercept, infliximab and adalimumab had a significantly greater risk of developing shingles than those on disease-modifying antirheumatic drugs, according to a study of more than 15,000 patients in the U.K. The findings appeared in the journal Annals of the Rheumatic Diseases.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY